Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Kuros Biosciences

Kuros Biosciences

Growth/Late
Zurich, SwitzerlandFounded 2000Sep 2022
Healthtech

Kuros Biosciences raised €6.3M in a Growth/Late round in Sep 2022. The company is based in Zurich, Switzerland. Investors in the round: Optiverder B.V, The Netherlands and Pegasus Global Opportunity Fund. Data as of Nov 2026.

← Kuros Biosciences
Amount raised
€6.3M
€6,263,702
Native amount
6,000,000 CHF
Stage
Growth/Late
growth equity
Investors
2

Provenance & confidence

High confidence
Amount
6,000,000 CHF
ECB-at-date → €6.3M · rate 0.9579 on 2022-09-16
High confidence
Source

startupticker.ch · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

2 named
Optiverder B.VThe Netherlands and Pegasus Global Opportunity Fund
Date
Sep 2022
Round type
growth equity
Amount (EUR)
€6.3M

Other rounds

same company

Related news